Literature DB >> 1909140

New insights into the immunopathology of tuberculosis.

G A Rook1, R al Attiyah, E Filley.   

Abstract

Tuberculosis is characterised by fever, weight loss and necrosis in both lesions and tuberculin skin test sites (Koch phenomenon), although the antigens of Mycobacterium tuberculosis are not directly toxic to the tissues. The tissue damage appears to be due to several interacting factors. First, M. tuberculosis induces an immunoregulatory disorder of which a raised percentage of agalactosyl IgG is a marker. This is seen also in rheumatoid arthritis and Crohn's disease and is associated with tissue-damaging inflammation. Subsequently, several properties of M. tuberculosis exacerbate this disorder by triggering cytokine release, and rendering tissues sensitive to the toxicity of tumor necrosis factor (TNF). Moreover, M. tuberculosis, but not bacillus Calmette-Guérin or several Mycobacterium avium strains, produces a factor which increases the toxicity of TNF for individual cells. Thus, M. tuberculosis may distort the normal protective role of TNF so that this cytokine becomes toxic to the host. The immunoregulatory disorder associated with agalactosyl IgG appears to be susceptible to immunotherapy, so novel types of treatment for the immunopathological component of tuberculosis are being explored.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909140     DOI: 10.1159/000163633

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  6 in total

1.  CtpV: a putative copper exporter required for full virulence of Mycobacterium tuberculosis.

Authors:  Sarah K Ward; Bassam Abomoelak; Elizabeth A Hoye; Howard Steinberg; Adel M Talaat
Journal:  Mol Microbiol       Date:  2010-09       Impact factor: 3.501

2.  A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy.

Authors:  G A Rook; P Onyebujoh; E Wilkins; H M Ly; R al Attiyah; G Bahr; T Corrah; H Hernandez; J L Stanford
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

3.  Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant.

Authors:  B G Marshall; M A Chambers; A Wangoo; R J Shaw; D B Young
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.

Authors:  Mark Hatherill; Hendrik Geldenhuys; Bernadette Pienaar; Sara Suliman; Phalkun Chheng; Sara M Debanne; Daniel F Hoft; W Henry Boom; Willem A Hanekom; John L Johnson
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

5.  IgG glycosylation in autoimmune-prone strains of mice.

Authors:  K B Bodman; P R Hutchings; P A Jeddi; P J Delves; G A Rook; N Sumar; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

6.  Mycobacterium tuberculosis PE25/PPE41 protein complex induces necrosis in macrophages: Role in virulence and disease reactivation?

Authors:  Smanla Tundup; Krishnaveni Mohareer; Seyed E Hasnain
Journal:  FEBS Open Bio       Date:  2014-09-16       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.